UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

____________________________

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement.

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)).

☐ Definitive Proxy Statement.

☒ Definitive Additional Materials.

☐ Soliciting Material Pursuant to §240.14a-12.

Aramark

(Exact name of Registrant as Specified in its Charter)

____________________________

Payment of Filing Fee (Check the appropriate box):
☒	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1) Title of each class of securities to which transaction applies:
	(2) Aggregate number of securities to which transaction applies:
	(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4) Proposed maximum aggregate value of transaction:
	(5) Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1) Amount Previously Paid:
	(2)Form, Schedule or Registration Statement No.:
	(3)Filing Party:
	(4) Date Filed:

Commencing on January 5, 2021, Aramark will be sending the following email to a number of its large institutional investors in connection with the Company’s upcoming Annual Meeting of Shareholders to be held on February 2, 2021.

Happy New Year. Wishing you the best in the year ahead.

We greatly appreciate the ongoing engagement that allowed us to gain your valued insight over the course of the year on a variety of topics, including corporate governance. As you know, we filed our definitive proxy statement on December 23rd, 2020 (Proxy) and your feedback was instrumental as we crafted our disclosures. As detailed further in our proxy, we took the following actions:

•Nominated one new independent director – Bridgette Heller – standing for election by shareholders at our February 2nd Annual Meeting. As detailed in the press release announcing her candidacy on December 17th, Bridgette’s impressive background and accomplishments further strengthen the overall Board’s skills and qualifications that align with the Company’s strategic vision (see pgs. 2-11; 18-19)

•Throughout fiscal ’20, and especially since March, the Board held substantially more meetings than the prior year in order to be a resource as the Company effectively managed through the impact of COVID-19(see pgs. 13-16)

•Remained highly focused on our ESG Priorities and Goals outlined in our Be Well. Do Well. plan that included establishing Aramark’s Executive Diversity Council and publishing the Healthy for Life® Impact Report that highlights our collaboration with the American Heart Association, among other initiatives. In a few weeks, we plan to share additional reporting on our progress in this important area (see pg. 17)

•Conducted a comprehensive review and RFP process related to our external audit, as a good corporate governance practice, and selected Deloitte as our new independent auditor(see pgs. 23-24)

•Implemented key compensation actions as we managed through the COVID-19 environment, while remaining committed to recognize, retain and incentivize employees as we focus on accelerating growth in the business (see pgs. 28-41)

•Aligned fiscal ’21 performance targets and weightings for our leadership with the overall business strategy (see pg. 49)

◦Net New Revenue 40%

◦Adjusted Operating Income Margin 40%

◦Free Cash Flow 20%

•Proposed amendment to the equity compensation plan to increase the share reserve that will provide the ability to grant appropriate equity-based awards going forward, continuing to align interests with shareholders (see pgs. 83-91)

•Proposed Employee Stock Purchase Plan as a new benefit to further the ownership mindset within the Company and allow participating employees to share in our value creation(see pgs. 92-96)

We look forward to engaging directly with you related to our proxy statement as a continued resource.

Best,

Felise